With the analysis among 244 patents, we discovered top 23 key players by total patent application. Regeneron Pharmaceuticals, Inc., Genentech, Inc., Eli Lilly & Co. are dominant in this area. They take 67.21% of the total patent filing.
New York, United States
Patent: 104
California, United States
Patent: 32
Indiana, United States
Patent: 28
California, United States
Patent: 14
Texas, United States
Patent: 10
Jiangsu Sheng, China
Patent: 9
California, United States
Patent: 8
New Jersey, United States
Patent: 6
California, United States
Patent: 5
Beijing Shi, China
Patent: 4
No data, please try another search term
With the analysis among related 97 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Eli Lilly & Co., Regeneron Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc. take 61.86% of patent filing during this period.
Indiana, United States
Patent: 28
New York, United States
Patent: 18
California, United States
Patent: 14
Jiangsu Sheng, China
Patent: 9
California, United States
Patent: 8
Guangdong Sheng, China
Patent: 2
Massachusetts, United States
Patent: 2
Shandong Sheng, China
Patent: 2
undefined undefined
Patent: 2
Beijing Institute of Heart Lung & Blood Vessel Diseases
With the analysis among related 97 patents in last 5 years, we discover 15 new entrants. Eli Lilly & Co., Arrowhead Pharmaceuticals, Inc., Suzhou Ruibo Biological Technology Co Ltd are the most active new entrants in this area.
Indiana, United States
Patent: 28
California, United States
Patent: 14
Jiangsu Sheng, China
Patent: 9
California, United States
Patent: 8
Guangdong Sheng, China
Patent: 2
Massachusetts, United States
Patent: 2
Shandong Sheng, China
Patent: 2
undefined undefined
Patent: 2
Beijing Institute of Heart Lung & Blood Vessel Diseases
undefined undefined
Patent: 1
With the analysis among 34 patents, we discovered top 5 universities and scientific research institutions by total patent application. University of Tokyo, Kumamoto University, Nanyang Technological University are dominant in this area. They take 52.94% of the total patent filing.
Kumamoto-ken, Japan
Patent: 3
Central Region, Singapore
Patent: 2
Hong Kong SAR, China
Patent: 1
Shandong Sheng, China
Patent: 1